Skip to main content
Erschienen in: World Journal of Urology 5/2013

01.10.2013 | Original Article

Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival

verfasst von: L. S. Mertens, R. P. Meijer, E. van Werkhoven, A. Bex, H. G. van der Poel, B. W. van Rhijn, W. Meinhardt, S. Horenblas

Erschienen in: World Journal of Urology | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To analyse whether the reported differences in nodal yield at pelvic lymph node dissection (PLND) for bladder cancer, between two hospitals, are reflected in the survival rates.

Patients and methods

We assessed follow-up data of all 174 patients (mean age: 62.7, median follow-up: 3 years) who underwent PLND between 1 January 2007 and 31 December 2009 at two different hospitals. PLND was performed according to a standardized template by the same urologists for comparable bladder cancer patients. Mean number of reported lymph nodes was 16 at hospital A versus 28 at hospital B. We compared the overall survival (OS), disease-specific survival (DSS) and recurrence-free survival (RFS) between both cohorts and performed a multivariate analysis.

Results

The cumulative probability for 2-year OS, DSS and RFS for hospital A are 61, 64 and 54 %, versus 58, 58 and 53 % for hospital B, respectively. Kaplan–Meier survival curves did not reveal statistically significant differences between both groups (OS: p log-rank = 0.75, DSS: p log-rank = 0.56, and RFS: p log-rank = 0.80). Also after adjustment for pT stage and neoadjuvant chemotherapy, survival was not significantly different between hospital A and hospital B.

Conclusion

Despite differences in lymph node yield in PLND specimens, this study reveals no significant differences in survival outcomes between both hospitals. Standardized histopathological methods should be agreed upon by pathologists before integrating nodal yield and subsequent lymph node density as indicators of the quality of surgery and as prognostic factors.
Literatur
1.
Zurück zum Zitat Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873PubMedCrossRef Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873PubMedCrossRef
2.
Zurück zum Zitat Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139PubMedCrossRef Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139PubMedCrossRef
3.
Zurück zum Zitat Roth B, Wissmeyer MP, Zehnder P, Birkhauser FD, Thalmann GN, Krause TM et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205PubMedCrossRef Roth B, Wissmeyer MP, Zehnder P, Birkhauser FD, Thalmann GN, Krause TM et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205PubMedCrossRef
4.
Zurück zum Zitat Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22:2781PubMedCrossRef Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22:2781PubMedCrossRef
5.
Zurück zum Zitat Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295PubMedCrossRef Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295PubMedCrossRef
6.
Zurück zum Zitat Kassouf W, Svatek RS, Shariat SF, Novara, G, Lerner SP, Fradet Y et al (2011) Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol [Epub ahead of print] Kassouf W, Svatek RS, Shariat SF, Novara, G, Lerner SP, Fradet Y et al (2011) Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol [Epub ahead of print]
7.
Zurück zum Zitat May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM et al (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 59:712PubMedCrossRef May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM et al (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 59:712PubMedCrossRef
8.
Zurück zum Zitat Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM (2006) Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176:53PubMedCrossRef Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM (2006) Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176:53PubMedCrossRef
9.
Zurück zum Zitat Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170:35PubMedCrossRef Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170:35PubMedCrossRef
10.
Zurück zum Zitat Jensen JB, Ulhoi BP, Jensen KM (2012) Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 19:39PubMedCrossRef Jensen JB, Ulhoi BP, Jensen KM (2012) Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 19:39PubMedCrossRef
11.
Zurück zum Zitat Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW et al (2012) Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes. J Urol 187(2):446–450 Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW et al (2012) Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes. J Urol 187(2):446–450
12.
Zurück zum Zitat Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60:946PubMedCrossRef Dorin RP, Daneshmand S, Eisenberg MS, Chandrasoma S, Cai J, Miranda G et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60:946PubMedCrossRef
13.
Zurück zum Zitat Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261PubMedCrossRef Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B et al (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186:1261PubMedCrossRef
14.
Zurück zum Zitat Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA et al (2008) Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 26:121PubMedCrossRef Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA et al (2008) Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 26:121PubMedCrossRef
15.
Zurück zum Zitat Quek ML, Flanigan RC (2009) The role of lymph node density in bladder cancer prognostication. World J Urol 27:27PubMedCrossRef Quek ML, Flanigan RC (2009) The role of lymph node density in bladder cancer prognostication. World J Urol 27:27PubMedCrossRef
16.
Zurück zum Zitat Bochner BH, Herr HW, Reuter VE (2001) Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166:2295PubMedCrossRef Bochner BH, Herr HW, Reuter VE (2001) Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 166:2295PubMedCrossRef
17.
Zurück zum Zitat Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876PubMedCrossRef Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876PubMedCrossRef
18.
Zurück zum Zitat Bennett VS, Varma M, Bailey DM (2008) Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens. J Clin Pathol 61:713 Bennett VS, Varma M, Bailey DM (2008) Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens. J Clin Pathol 61:713
19.
Zurück zum Zitat Winstanley AM, Sandison A, Bott SR, Dogan A, Parkinson MC (2002) Incidental findings in pelvic lymph nodes at radical prostatectomy. J Clin Pathol 55:623PubMedCrossRef Winstanley AM, Sandison A, Bott SR, Dogan A, Parkinson MC (2002) Incidental findings in pelvic lymph nodes at radical prostatectomy. J Clin Pathol 55:623PubMedCrossRef
20.
Zurück zum Zitat Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR (2010) Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 116:1901PubMedCrossRef Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR (2010) Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 116:1901PubMedCrossRef
21.
Zurück zum Zitat Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R (2004) Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 45:257PubMedCrossRef Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R (2004) Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. Eur Urol 45:257PubMedCrossRef
22.
Zurück zum Zitat Herr H, Lee C, Chang S, Lerner S (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171:1823PubMedCrossRef Herr H, Lee C, Chang S, Lerner S (2004) Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 171:1823PubMedCrossRef
Metadaten
Titel
Differences in histopathological evaluation of standard lymph node dissections result in differences in nodal count but not in survival
verfasst von
L. S. Mertens
R. P. Meijer
E. van Werkhoven
A. Bex
H. G. van der Poel
B. W. van Rhijn
W. Meinhardt
S. Horenblas
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2013
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-012-0916-z

Weitere Artikel der Ausgabe 5/2013

World Journal of Urology 5/2013 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.